Biomarkers

Diabetes and CKD: The Patient Experience, Clinical Research and the Promise of Precision Medicine

July 29, 2020

Exploring Changes of Myeloid Cells with Chromogenic Multiplex IHC in Advanced Liver Cancer

June 08, 2020

Multi-disciplinary Measurement of Host Biomarkers and Correlates in Infection and Immunity

June 26, 2020

Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 2

May 12, 2020

Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1

May 11, 2020

Optimizing Your CRO Selection Process for Pharmaceutical Drug Discovery

April 22, 2020

Evaluating Biomarkers During Clinical Trials for Immunotherapies: A Case Study on the Pioneer Project

November 27, 2019

NASH Clinical Drug Development: Imaging the Liver and Beyond

October 22, 2019
Blogs

Six of the Latest NASH/NAFLD Webinars
News

Biomarkers and Clinical Risk Factors Combined for More Accurate Atrial Fibrillation Diagnosis

Expansion Cohorts in Early Development of Anticancer Agents

February 21, 2019

From Biomarkers to Companion Diagnostics: Advances in Immuno-Oncology Clinical Trial Assay Development – Broadcast 2

January 22, 2019

From Biomarkers to Companion Diagnostics: Advances in Immuno-Oncology Clinical Trial Assay Development – Broadcast 1

January 22, 2019

Ligand Binding Assays and Hybrid LC-MS Quantitation of Biotherapeutics and Biomarkers

December 03, 2018

Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials

October 22, 2018

Identifying Spatial Expression Patterns in the Tumor Microenvironment – Broadcast 2

October 09, 2018